Copyright
©The Author(s) 2024.
World J Radiol. Dec 28, 2024; 16(12): 794-805
Published online Dec 28, 2024. doi: 10.4329/wjr.v16.i12.794
Published online Dec 28, 2024. doi: 10.4329/wjr.v16.i12.794
Table 3 Subgroup analysis in journal types, median (interquartile range)
Radiomics quality score | Median score | Imaging journals | Clinical journals | Comprehensive journals | P value |
Total 36 points | 11 (9–14) | 11 (8.25–14) | 12 (9–16) | 11.5 (8–15) | 0.379 |
Domain 1: Protocol quality and stability in image and segmentation (0 to 5 points) | 1 (1–2) | 1 (1–2) | 2 (1–2) | 1 (1–2) | 0.039 |
Image protocol quality (2) | 1 (1–1) | 1 (1–1) | 1 (1–1) | 1 (1–1) | 0.201 |
Multiple segmentations (1) | 0 (0–1) | 0 (0–1) | 0 (0–1) | 0 (0–0.25) | 0.03 |
Phantom study on all scanners (1) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.205 |
Imaging at multiple time points (1) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.383 |
Domain 2: Feature selection and validation (-8 to 8 points) | 5 (5–6) | 5 (5–6) | 5 (5–6) | 5 (1–2) | 0.553 |
Feature reduction or adjustment for multiple testing (-3 or 3) | 3 (3–3) | 3 (3–3) | 3 (3–3) | 3 (3–3) | 0.539 |
Validation (-5, 2, 3, 4, or 5) | 2 (2–3) | 2 (2–3) | 2 (2–3) | 2 (1.5–2.25) | 0.585 |
Domain 3: Biologic/clinical validation and utility (0 to 6points) | 1 (1–2) | 1 (0.25–2) | 1 (1–2) | 1 (0–2) | 0.613 |
Multivariable analysis with non-radiomics features (1) | 1 (0–1) | 1 (0–1) | 1 (0–1) | 1 (0–1) | 0.059 |
Detect and discuss biological correlates (1) | 0 (0–1) | 0 (0–0) | 0 (0–1) | 0 (0–1) | 0.075 |
Comparison to ‘gold standard’ (2) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.669 |
Potential clinical utility (2) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.628 |
Domain 4: Model performance index (0 to 5 points) | 3 (2–4) | 3 (2–4) | 3 (2–4) | 3 (2–5) | 0.315 |
Cut-off analyses (1) | 1 (0–1) | 0 (0–1) | 1 (0–1) | 1 (0–1) | 0.101 |
Discrimination statistics (2) | 2 (1–2) | 2 (1.5–2) | 2 (1–2) | 2 (1.75–2) | 0.071 |
Calibration statistics (2) | 1 (0–2) | 1 (0–2) | 1 (0–2) | 0.5 (0–2) | 0.175 |
Domain 5: High level of evidence (0 to 8 points) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.588 |
Prospective study registered in a trial database (7) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.435 |
Cost-effectiveness analysis (1) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.236 |
Domain 6: Open science and data (0 to 4 points) | 0.653 (0–1) | 1 (0–1) | 1 (0–1) | 0.5 (0–2) | 0.649 |
- Citation: Cao X, Xiong M, Liu Z, Yang J, Kan YB, Zhang LQ, Liu YH, Xie MG, Hu XF. Update report on the quality of gliomas radiomics: An integration of bibliometric and radiomics quality score. World J Radiol 2024; 16(12): 794-805
- URL: https://www.wjgnet.com/1949-8470/full/v16/i12/794.htm
- DOI: https://dx.doi.org/10.4329/wjr.v16.i12.794